December 11, 2025 · Form 4 insider transaction
Krempa David bought 5,300 shares of Eton Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.; The restricted stock units vest immediately as of the award date.